— · biotech · diagnostics · genomics
One round we have observed, with the investors the report named. Every figure below came from a named source, and where the company reported the raise to the SEC itself, that is shown beside it.
Undisclosed round · May 2026 · $26M
ARCH Venture Partners lead, F-Prime Capital, Primer Ventures
Reported by Ventureburn
Missing a round, or an investor who was in one? Tell us.